October 15, 2024 01:00 AM EDT
Financing

For­bion rais­es €2.1B for two new biotech funds af­ter se­ries of com­pa­ny ex­its

Drew Armstrong

Executive Editor

Dutch biotech in­vestor For­bion has raised two new funds to put in­to biotech com­pa­nies, just 18 months af­ter its last ma­jor raise and fol­low­ing a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Two GSK tri­als with long-act­ing drug in chron­ic rhi­nos­i­nusi­tis hit pri­ma­ry end­points

Pfiz­er de­tails re­sults from failed Phase 3 tri­al of Duchenne mus­cu­lar dy­s­tro­phy gene ther­a­py 

No­vo Nordisk files 18 law­suits against GLP-1 com­pounders in 44 days

No­var­tis used a PRV to speed Kisqal­i's lat­est in­di­ca­tion, FDA says

Eli Lil­ly re­veals £279M in­vest­ment in the UK through new gov­ern­ment deal

sponsored

Join the Gen­Script Biotech Glob­al Fo­rum: Un­lock­ing In­no­va­tions in Cell and Gene Ther­a­pies

A service from the Financial Times